Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
Fibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma in young patients, and its lack of association with underlying liver dise...
Main Authors: | Oscar Suarez, María Perez, Martin Garzon, Rodrigo Daza, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique P. de Leon, Jacqueline Mugnier, Oscar Beltrán, Adriana Varón |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/7521986 |
Similar Items
-
Hyperammonemic encephalopathy: An unusual presentation of fibrolamellar hepatocellular carcinoma
by: Nimish Thakral, et al.
Published: (2020-01-01) -
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
by: Rodrigo Cañada Trofo Surjan, et al.
Published: (2020-04-01) -
Hyperammonemia: What Urea-lly Need to Know: Case Report of Severe Noncirrhotic Hyperammonemic Encephalopathy and Review of the Literature
by: Ruby Upadhyay, et al.
Published: (2016-01-01) -
Valproate Associated Hyperammonemic Encephalopathy
by: Wadzinski, Jim, et al.
Published: (2007) -
Valproate-Induced Hyperammonemic Encephalopathy
by: J Gordon Millichap
Published: (2006-07-01)